← All indications
Intermittent Claudication
A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.
Drugs by status
Approved for this indication (3)
Phase 4 trials (7)
Phase 3 trials (12)
Phase 2 trials (22)
Phase 1 trials (12)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (18)
- AstraZeneca
- Yungjin Pharm. Co., Ltd.
- Danish Heart Foundation
- Hanyang University
- Inje University
- Kyung Hee University
- Los Angeles Biomedical Research Institute
- Monash University
- Seoul National University
- University of Nebraska
- Wake Forest University
- Yonsei University
- Aalborg University
- Colorado Prevention Center
- University of California, Los Angeles
- Hallym University
- Department of Veteran Affairs
- University of Colorado
Organization Involved with Phase 3 Indications (21)
- Kos Pharmaceuticals
- Leadiant Biosciences, Inc.
- National Heart, Lung, and Blood Institute (NHLBI)
- Aarhus University
- Central Jutland Regional Hospital
- Harvard University
- Dartmouth University
- Herning Hospital
- Hoosier Cancer Research Network
- Southern Illinois University
- University of Rochester
- Leiden University
- Jacksonville Center for Clinical Research
- ActivBiotics Pharma
- University of Massachusetts
- Western Suburban Cardiologists, Ltd.
- Baptist Clinical Research
- Asheville Cardiology Associates
- University of Rennes
- University of Antwerp
- Noordwest Ziekenhuisgroep
Organization Involved with Phase 2 Indications (50)
- Biomarin
- Kowa
- Genzyme
- Sanofi
- Novartis
- Aldagen
- Angiogenix
- Diffusion Pharmaceuticals LLC
- MultiGene Vascular Systems Ltd.
- NicOx
- Nissan Chemical Industries
- Pluristem Ltd.
- Valentis
- Cytokinetics
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- University of Pennsylvania
- Ajou University
- Baylor University
- Dong-A University
- Duke University
- Korea University
- Kyushu University
- Ilsan Hospital
- Stanford University
- University of Hamburg
- University of Heidelberg
- University of Kentucky
- University of Virginia
- Chinese University of Hong Kong
- +20 more
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (8)